Amid plans to transfer manufacturing for an investigational vaccine to a souped-up plant in Pennsylvania, GSK is parting ways ...

CEO Emma Walmsley maintained that continued investment in the U.S. is a priority for the pharma to ensure its medicines for ...

GlaxoSmithKline: Attention Is Now Shifting To Vaccine Manufacturing Aug. 21, 2020 9:39 AM ET GSK plc (GSK) Stock AZN, DVAX, IBIO MRNA PFE SNY VIR GSK 27 Comments ...

Britain's GSK will shift production of the world's first effective malaria vaccine to Indian COVID-19 vaccine developer Bharat Biotech, as part of global efforts to battle the deadly fever, the ...

GSK is laying out €250 million to bolster vaccine manufacturing with a new facility to help make free-dried shots, including for shingles and RSV.

GSK Seeks FDA Approval For RSV Vaccine In More Adults: Retail Sees No Reason To Shift Their Bullish Stance© Stocktwits GSK's Sentiment Meter and Message Volume as of 8:30 a.m. ET on July 14, 2025 ...

The centrepiece of the new investment is a multi-purpose facility capable of manufacturing sterile liquid vaccines and medicines, for which GSK says there is "ever increasing demand," and a ...

Digital twins of manufacturing processes are being explored in pharmaceutical manufacturing for the benefits that can be harnessed from a real-time simulation of the actual process. In 2020, GSK ...